Avadel Pharmaceuticals Plc Files SEC Form 8-K, Current Report: (Oct. 17, 2024).

Avadel Pharmaceuticals Plc filed a Form 8-K with the U.S. Securities and Exchange Commission on October 17, 2024. This form is used to report material events or corporate changes that are important to investors and have not been previously reported. The filing provides current information on specific events and is a formal document submitted by publicly-traded companies. [Extracted from the article]